OncoTargets and Therapy (Dec 2021)
Hsa_circ_0006916 Knockdown Represses the Development of Hepatocellular Carcinoma via Modulating miR-599/SRSF2 Axis [Retraction]
Abstract
Zhu Z, Shen S, Zhao S, Wang Z. Onco Targets Ther. 2020;13:11301–11313. At the authors request, the Editor and Publisher of OncoTargets and Therapy wish to retract the published article. The authors informed the journal that the author, Sen Zhao, was added to the paper as an author without their knowledge or permission. In addition, the authors have also informed the journal that no ethical approval was given by the ethics committee of the First Affiliated Hospital of Henan University despite the article stating research approval had been provided. Given both issues breach our editorial policies the authors decided to retract the article. Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”. This retraction relates to this paper
